Midjourney, a company that until recently had been known for its AI image generation models, drastically pivoted this week into what it’s calling “a new era” for the company. It started by unveiling a new division called Midjourney Medical built around a whole-body ultrasound scanner the company says will be “in many ways superior to even MRI machines”, with scans taking as little as 60 seconds and requiring no radiation or magnetic fields. The scanner lowers patients into a ring of underwater transducers that emit and record ultrasonic waves from every angle, reconstructing a 3D map of the body roughly 100 times faster than current MRI technology. The company has grand ambitions for its new scanner. It plans to open a San Francisco spa at the end of 2027 with 10 scanners and wants to scale to 50K scanners worldwide and a billion scans per month by 2031.
Midjourney’s scanner elicited a range of reactions. Some hailed it as “the most significant new imaging modality in 50 years” and predicted that it would herald a new era of preventative medicine, with the potential to save many lives. Others were more skeptical. As psychiatrist and blogger Scott Alexander laid out, ultrasound physically cannot penetrate bone or air, ruling out the brain, lungs, and bowels, which is precisely why MRI and CT remain necessary for most serious diagnostic work. Radiologists he consulted were uniformly critical, with one noting that the entire premise rests on the unproven assumption that earlier detection of incidental abnormalities improves patient outcomes.
This is the same reason the medical establishment already discourages whole-body screening MRIs today: they cost about $2K, are not recommended by the American College of Radiology due to insufficient evidence of benefit, and carry high false-positive rates in asymptomatic populations. Nevertheless, the strongest case for Midjourney’s approach may simply be convenience and cost, since the underlying sensor technology should scale far more cheaply than MRI’s giant magnets.
Important Disclosures
This material has been distributed solely for informational and educational purposes only and is not a solicitation or an offer to buy any security or to participate in any trading strategy. All material presented is compiled from sources believed to be reliable, but accuracy, adequacy, or completeness cannot be guaranteed, and Contrary LLC (Contrary LLC, together with its affiliates, “Contrary”) makes no representation as to its accuracy, adequacy, or completeness.
The information herein is based on Contrary beliefs, as well as certain assumptions regarding future events based on information available to Contrary on a formal and informal basis as of the date of this publication. The material may include projections or other forward-looking statements regarding future events, targets or expectations. Past performance of a company is no guarantee of future results. There is no guarantee that any opinions, forecasts, projections, risk assumptions, or commentary discussed herein will be realized. Actual experience may not reflect all of these opinions, forecasts, projections, risk assumptions, or commentary.
Contrary shall have no responsibility for: (i) determining that any opinions, forecasts, projections, risk assumptions, or commentary discussed herein is suitable for any particular reader; (ii) monitoring whether any opinions, forecasts, projections, risk assumptions, or commentary discussed herein continues to be suitable for any reader; or (iii) tailoring any opinions, forecasts, projections, risk assumptions, or commentary discussed herein to any particular reader’s objectives, guidelines, or restrictions. Receipt of this material does not, by itself, imply that Contrary has an advisory agreement, oral or otherwise, with any reader.
Contrary is registered with the Securities and Exchange Commission as an investment adviser under the Investment Advisers Act of 1940. The registration of Contrary in no way implies a certain level of skill or expertise or that the SEC has endorsed Contrary. Investment decisions for Contrary clients are made by Contrary. Please note that, although Contrary manages assets on behalf of Contrary clients, Contrary clients may take any position (whether positive or negative) with respect to the company described in this material. The information provided in this material does not represent any investment strategy that Contrary manages on behalf of, or recommends to, its clients.
Different types of investments involve varying degrees of risk, and there can be no assurance that the future performance of any specific investment, investment strategy, company or product made reference to directly or indirectly in this material, will be profitable, equal any corresponding indicated performance level(s), or be suitable for your portfolio. Due to rapidly changing market conditions and the complexity of investment decisions, supplemental information and other sources may be required to make informed investment decisions based on your individual investment objectives and suitability specifications. All expressions of opinions are subject to change without notice. Investors should seek financial advice regarding the appropriateness of investing in any security of the company discussed in this presentation.
Please see www.contrary.com/legal for additional important information.
